Search
Feed aggregator
ImmunityBio Wins FDA Approval for First IL-15 Superagonist for NMIBC
ImmunityBio Wins FDA Approval for First IL-15 Superagonist for NMIBC 4/23/2024
FDA Rejects Abeona’s Epidermolysis Bullosa Cell Therapy, Asks for CMC Data
FDA Rejects Abeona’s Epidermolysis Bullosa Cell Therapy, Asks for CMC Data 4/23/2024
Supreme Court Denies Vanda’s Petition in Hetlioz Patent Case Against Teva
Supreme Court Denies Vanda’s Petition in Hetlioz Patent Case Against Teva 4/23/2024
Alvotech, Teva Enlist New Partner to Expand Access to Humira Biosimilar in US
Alvotech, Teva Enlist New Partner to Expand Access to Humira Biosimilar in US 4/19/2024
FDA Requires Boxed Warning for Secondary Cancers on CAR-T Therapies
FDA Requires Boxed Warning for Secondary Cancers on CAR-T Therapies 4/19/2024
Genentech Wins FDA Approval for First Adjuvant Therapy for ALK-Positive, Early NSCLC
Genentech Wins FDA Approval for First Adjuvant Therapy for ALK-Positive, Early NSCLC 4/19/2024
Sanofi Cuts Jobs in US Vaccines Division as Part of Restructuring
Sanofi Cuts Jobs in US Vaccines Division as Part of Restructuring 4/19/2024
J&J, Other Q1 Financials Beg the Queston: What Does It Mean to Miss Expectations?
J&J, Other Q1 Financials Beg the Queston: What Does It Mean to Miss Expectations? 4/19/2024
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies 4/19/2024
Weight-Loss Drug Startup Metsera Launches with $290M, Looks to Tap Lucrative Obesity Market
Weight-Loss Drug Startup Metsera Launches with $290M, Looks to Tap Lucrative Obesity Market 4/18/2024
Intra-Cellular Looks to Raise $500M in Public Offering Following Phase III MDD Win
Intra-Cellular Looks to Raise $500M in Public Offering Following Phase III MDD Win 4/18/2024
Cerevel Gets Phase III Parkinson’s Win on Heels of $8.7B AbbVie Acquisition
Cerevel Gets Phase III Parkinson’s Win on Heels of $8.7B AbbVie Acquisition 4/18/2024
Most Doses of Lilly’s Zepbound and Mounjaro in Short Supply Through Q2: FDA
Most Doses of Lilly’s Zepbound and Mounjaro in Short Supply Through Q2: FDA 4/18/2024
Teva, Alvotech Secure FDA Approval for Stelara Biosimilar with Early 2025 Launch
Teva, Alvotech Secure FDA Approval for Stelara Biosimilar with Early 2025 Launch 4/18/2024
Roche’s Ocrevus Achieves Near-Complete Reduction of Relapse, Lesions in MS
Roche’s Ocrevus Achieves Near-Complete Reduction of Relapse, Lesions in MS 4/18/2024
Bioversity Program Preps Grads for Early-Career Life Science Roles
Bioversity Program Preps Grads for Early-Career Life Science Roles 4/18/2024
How to Deal With Layoff-Related Stress
How to Deal With Layoff-Related Stress 4/18/2024
Career Coach: How to Look Professional in Virtual Meetings
Career Coach: How to Look Professional in Virtual Meetings 4/18/2024
5 Top Companies Hiring Oncology Jobs
5 Top Companies Hiring Oncology Jobs 4/18/2024
Lilly Eyes Zepbound Label Expansion After Clearing Phase III Sleep Apnea Study
Lilly Eyes Zepbound Label Expansion After Clearing Phase III Sleep Apnea Study 4/17/2024
World Pharma News
- Next-generation microbiome medicine may revolutionize the treatment of Parkinson's and similar disorders
- A cellular protein, FGD3, boosts breast cancer chemotherapy, immunotherapy
- Common gout drug may reduce risk of heart attack and stroke
- New nasal vaccine has potential to transform respiratory disease prevention
- MIT research finds particles that enhance mRNA delivery could reduce vaccine dosage and costs